http://www.fpnotebook.com/
Azathioprine
Aka: Azathioprine, Imuran- Indications
- Renal homograft maintenance
- Myasthenia Gravis
- Systemic Lupus Erythematosus (Lupus Nephritis)
- Acute Glomerulonephritis
- Pharmacology
- Imidazolyl derivative of mercaptopurine
- Metabolized to mercaptopurine as active ingredient
- Structural Analogue Chemotherapy (purine)
- Imidazolyl derivative of mercaptopurine
- Adverse effects (similar to mercaptopurine)
- Bone Marrow suppression
- Skin rash
- Drug Fever
- Nausea, Vomiting or Diarrhea
- Hepatic dysfunction
- Monitoring
Imuran (C0699279) |
|
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D001379 |
| English | Immuran, imuran, immuran, Imuran |
| French | Imuran |
| German | Imuran, Immuran |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Azathioprine (C0004482) |
|
|---|---|
| Definition (CHV) | an immunosppressive drug |
| Definition (CHV) | an immunosppressive drug |
| Definition (CHV) | an immunosppressive drug |
| Definition (CHV) | an immunosppressive drug |
| Definition (MSH) | An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) |
| Definition (CSP) | immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis; possible carcinogen. |
| Definition (NCI) | A purine analogue with cytotoxic and immunosuppressive activity. Azathioprine is a prodrug that is converted by hepatic xanthine oxidase to its active metabolite 6-mercaptopurine (6-MP). 6-MP is further metabolized by hypoxanthine-guanine phosphoribosyltransferase (HGPRT) into 6-thioguanosine-5'-phosphate (6-thio-GMP) and 6-thioinosine monophosphate (6-thio-IMP), both inhibit nucleotide conversions and de novo purine synthesis. This leads to inhibition of DNA, RNA, and protein synthesis. As a result, cell proliferation may be inhibited, particularly in lymphocytes and leukocytes. |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D001379 |
| SnomedCT | 317390007, 327060009, 391800005, 111165009, 372574004 |
| English | Azathioprine, Azothioprine, 1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-, Azathioprine [gastrointestinal], Azathioprine [gi], Azathioprine [immunosuppress], 6-[(1-Methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine, azathioprine, Azathioprine [immunosuppressant], AZTP, Azathioprine [gastrointestinal] (product), azathioprine (medication), Azathioprine [immunosuppressant] (product), Azathioprine - chemical (substance), AZATHIOPRINE, Azathioprine [Chemical/Ingredient], atps, ATP, azothioprine, azaTHIOprine, AZT - Azathioprine, Azathioprine (product), Azathioprine (substance), Azathioprine - chemical, Azathioprine [gastrointestinal] (substance), AZA |
| Swedish | Azatioprin |
| Czech | azathioprin |
| Spanish | Azathioprine - chemical, Azathioprine [immunosuppressant], azatioprina (gastrointestinal) (producto), azatioprina (gastrointestinal), azatioprina (producto), azatioprina (sustancia), azatioprina, Azatioprina |
| Finnish | Atsatiopriini |
| Italian | Azotioprina, Azatioprina |
| Russian | IMURAN, AZATIOPRIN, АЗАТИОПРИН, ИМУРАН |
| Japanese | イムラン, アザチオプリン |
| Polish | Azatiopryna |
| French | Azathioprine |
| German | Azathioprin |
| Portuguese | Azatioprina |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |